Drawing for AXIOMER

USPTO serial 79192823

AXIOMER

Reviewed by CopyMark Law Group

Reg. 5229979Status 404
Filing date
Status date
Registration date
Jun 27, 2017
Examiner
EVANKO, PATRICIA MALESARDI
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AXIOMER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Krista Weber Powell

Krista Weber Powell TRASKBRITT, P.C.230 South 500 East, #300Salt Lake City, UT 84102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical compounds for scientific or research purposes ]SECTION 7(e) - CANCELLED—
005[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ]SECTION 71 - CANCELLED—
042[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ]SECTION 7(e) - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 8, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 14, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 14, 2024INPCINVALIDATION PROCESSED—
Sep 13, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 12, 2024C71TCANCELLED SECTION 71—
Jun 27, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 12, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Apr 8, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 28, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 28, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 28, 2017FIMPFINAL DISPOSITION PROCESSED—
Sep 27, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 8, 2017LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Aug 8, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 8, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 27, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 24, 2017ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 20, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 6, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 10, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2016RFNTREFUSAL PROCESSED BY IB—
Oct 27, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 27, 2016RFRRREFUSAL PROCESSED BY MPU—
Oct 11, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 7, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2016DOCKASSIGNED TO EXAMINER—
Oct 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance